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organ culture model with human saphenous vein.2 Our goal
in this study was the determination of whether an injury-
specific profile of gene expression is distinct from the changes
in gene expression that would be expected to occur in the tis-
sues after placement in an organ culture environment.
For an analysis of injury-specific gene expression in
human saphenous vein, we produced a reproducible and
histologically identifiable crush injury to a portion of a
vein segment before culture. This produced a necrotic
zone surrounded with healthy vascular tissue on histologic
examination results. Gene expression analysis of cultured
vein segments with and without crush injury was per-
formed at defined periods and compared with one another
at each time point and to gene expression of the vein at
the time of harvest.
METHODS AND MATERIALS
Experimental design. Restriction fragment differen-
tial display (RFDD; Display Systems Biotech, Vista, Calif)
was used for the comparison of the gene expression profile
in seven sets of vein, with the first set representing gene
expression at the time of harvest of the vein and the other
six sets representing different lengths of time in culture
Vein graft stenosis is thought to be the clinical result
of the vascular response to injury. In animal models, the
response to injury has been shown to include the processes
of cell migration, cell proliferation, and accumulation of
extracellular matrix. There is a paucity of information on
the response to injury in human blood vessels. Modern
techniques of gene expression analysis make possible the
identification of differentially expressed genes with small
amounts of syngeneic material.1
We have shown that cell proliferation and remodeling of
the layers of the vessel wall can be examined in vitro in an
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The sequence of gene expression in cultured
human saphenous vein after injury
John J. Castronuovo, Jr, MD, and Ray M. Price, PhD, Morristown, NJ
Objective: The objective of this study was a description of changes in gene expression that occur in response to mechan-
ical injury of cultured human saphenous vein.
Methods: Restriction fragment differential display (Display Systems Biotech, Vista, Calif) was used for the comparison of
the gene expression profile in seven sets of vein, with the first set representing gene expression at the time of harvest of
the vein and the other six sets representing different lengths of time in culture with or without crush injury. All seven
sets were from a single, freshly harvested vein. Each set contained eight separate vein segments. The first set (Set 1) was
taken from the freshly harvested vein, and the RNA was immediately extracted. This set reflects the in vivo gene expres-
sion profile at the time of harvest. Three sets of vein segments (Sets 2, 4, and 6) were cultured for 24, 48, or 72 hours
after harvest (culture only). Three sets of vein segments (Sets 3, 5, and 7) were harvested, crush-injured, and then cul-
tured for 24, 48, or 72 hours (crush injury + culture). The gene expression profiles of these six cultured sets of vein seg-
ments were compared with the gene expression profile of the set of vein segments that were obtained at harvest.
Results: The crush injury of the vein segments resulted in the up-regulated expression of 21 identified (including
inducible nitric oxide synthase) and nine unknown genes and in the down-regulated expression of eight identified and
seven unknown genes within the first 72 hours after harvest. The vein segments that were cultured without crush injury
had the up-regulated expression of nine identified and seven unknown genes and the down-regulated expression of five
identified (including platelet-derived growth factor–B and transforming growth factor–β2) and seven unknown genes
within the first 72 hours after harvest. The pattern of gene regulation after transmural crush injury revealed eight genes
whose products support cell migration and seven genes whose products oppose cell proliferation.
Conclusion: The comparison of gene expression between those vein segments designated culture only and those vein
segments designated crush injury and culture shows that some cells of the vein segments express phenotypic changes
that are consistent with cell migration. Further studies of gene expression changes in vitro may elucidate the endoge-
nous response of vascular tissue to injury. (J Vasc Surg 2002;35:146-51.)
with or without crush injury. All seven sets were from a
single, freshly harvested vein. Each set contained eight
separate vein segments. The first set (Set 1) was taken
from the freshly harvested vein, and the RNA was imme-
diately extracted. This set reflects the in vivo gene expres-
sion profile at the time of harvest. Three sets of vein
segments were cultured for 24, 48, or 72 hours after har-
vest (culture only; Sets 2, 4,and 6, respectively). Three sets
of vein segments were harvested, crush-injured, and then
cultured for 24, 48, or 72 hours (crush injury + culture;
Sets 3, 5, and 7, respectively). The gene expression profiles
of these six cultured sets of vein segments were compared
with the gene expression profile of the set of vein seg-
ments that were obtained at harvest.
Tissue harvesting, injury, and culture. Excess
saphenous vein harvested for arterial bypass grafting was
obtained from a single patient after Institutional Review
Board approval of the study protocol. The vein segments
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(eight segments per set) were stored and prepared for cul-
ture as previously described.2 Set 1 (harvest) was snap
frozen in liquid nitrogen. Sets 2, 4, and 6 were placed in
minimal medium2 and organ cultured for 24, 48, and 72
hours, respectively. Sets 3, 5, and 7 were injured with the
crushing of two areas of the vein wall 180 degrees opposite
one another between the jaws of serrated forceps and sub-
sequently cultured for 24, 48, or 72 hours, respectively. At
harvest and at the end of each culture period, the RNA was
extracted for gene expression analysis with RFDD.
Polyadenylated RNA was used as the input for RFDD.
Total RNA was isolated from the cultured human saphe-
nous vein segments with homogenization (10 seconds in
a rotor-stator homogenizer, Omni International, Marietta,
Ga) in guanidine isothiocyanate and 2-mercaptoethanol
and binding to a silica column (RNeasy Midi Kit, QIA-
GEN Inc, Valencia, Calif). A proteinase K digestion (10
minutes at 55°C, before addition to the column) and an
on-column deoxyribonuclease I digestion (15 minutes at
room temperature) were added to the manufacturer’s pro-
tocol to ensure the isolation of intact, high-quality RNA.
Poly(A) RNA (messenger RNA [mRNA]) was isolated
from total RNA with the Oligotex mRNA Mini Kit (QIA-
GEN). The mRNA then was sent to Display Systems
Biotech (Vista, Calif, and Copenhagen, Denmark) for
their displayPROFILE analysis service with RFDD. The
results of the RFDD were returned as pictures of the gels
that were run to display the amplified bands of approxi-
mately 100 to 500 base pairs in length. On each gel, the
lanes were run, in the same order, from the first to the sev-
enth, with the Sets 1 to 7 organized for reading from left
to right on the gel. In this way, the differential expression
of genes with the different experimental conditions of
each set could be compared easily (Fig 1). Differential
gene expression was determined with densitometry of 
the band within the fragment sizes of interest. Up-regu-
lated genes were those whose expression was at least two
times that of the harvest Set 1 (Fig 1, arrow), and down-
Fig 1. Two of 64 expression windows (Eu) used for restriction
fragment differential display. Lane numbers correspond to set
numbers for each culture/injury condition. Lane 1 in each Eu
represents gene expression profile of harvested saphenous vein
samples (in vivo gene expression; Set 1). Lanes 2, 4, and 6 repre-
sent gene expression profiles of cultured saphenous vein samples
after 24, 48, and 72 hours of culture (Sets 2, 4, and 6, respec-
tively). Lanes 3, 5, and 7 represent gene expression profiles of
crush-injured saphenous vein samples after 24, 48, and 72 hours
of culture (Sets 3, 5, and 7, respectively). Up-regulated genes
(arrows) are clearly visible in lane 4 of Eu 13 at 321 base pairs
(unknown) and lane 7 of Eu 14 at 104 base pairs (TAF2A).
Fig 2. Hematoxylin and eosin–stained section of crush-injured
vein (Sets 3, 5, and 7; original magnification, 100×). Necrotic
zone (arrow) was evidenced with disintegrating nuclei after 2 days
in organ culture.
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regulated genes were those whose expression was at most
one half that of the harvest Set 1.1,3 Once the specific
bands were identified as differentially expressed, tentative
identification of that band was performed with the enter-
ing of the size of the band (identified on each) and the
expression window (the specific trinucleotide sequence
used for amplification) in Display Systems Biotech’s
displayFIT Program, which returns the possible genes that
fit the specific restriction fragment and expression window.
The displayFIT program also returns the reverse expres-
sion window—the sequence that defines the opposite end
(3´ versus 5´) of the restriction fragment that also specifi-
cally identifies a given gene. Both display windows must
agree before the report of a specific gene’s differential
expression can be made.
After the identification of a differentially expressed gene,
the GeneCards database4 was consulted for synonyms and
the Human Genome Nomenclature Committee–approved
gene names. The names of the genes that were specifically
identified as differentially expressed in this study, with the
GenBank accession numbers, are listed in Tables I and II.
A third table is included in the Web version of this
manuscript and contains the descriptions of the genes
identified in this study in alphabetical order (Table III,
online only).4 Additional detailed methods also are
described in the web version of this manuscript.
RESULTS
Histology. The organ cultures were monitored daily.
No cell spreading onto the culture dish was observed in the
cultured vessel segments. Examination results of the hema-
toxylin and eosin–stained sections revealed intact nuclei
and no evidence of necrosis or cellular degeneration at har-
vest or after culture in the vein segments that were not sub-
jected to crush injury. In the crush-injured segments (Sets
3, 5, and 7), two necrotic zones, approximately 2 mm 
in width each, were observed. These necrotic zones were
surrounded by healthy tissue (Fig 2). 
Modulation of gene expression. RFDD of extracted
mRNA resulted in the profile of more than 10,000 restric-
tion fragments (Fig 1). The size (Fig 1, scale) and expres-
sion window (Fig 1, Eu) were used to identify up-regulated
or down-regulated expressed genes.
Set 1 represents harvested vein. Sets 2 through 7 repre-
sent gene expression as the result of experimental manipula-
tions: culture or crush injury and culture. Up-regulation 
or down-regulation of genes expressed in Sets 2 through 7
(Fig 1, lanes 2 to 7) are on the basis of a comparison with the
gene expression profile at harvest of Set 1 (Fig 1, lane 1).
The crush injury of the vein segments (Sets 3, 5, and
7) resulted in the injury-specific, up-regulated expression
of 21 identified and nine unknown genes and in the
down-regulated expression of eight identified and seven
Table I. Crush injury–modulated gene expression
24-Hour organ culture (Set 3) 48-Hour organ culture (Set 5) 72-Hour organ culture (Set 7)
Up-regulated (↑)
INOS [L09210] [L24553] — INOS [L09210] [L24553]
MMP9 [J05070] EFEMP1 [AF072693] EFEMP1 [AF072693]
MMP23B [AL031282] NTRK1 [M23102] NTRK1 [M23102]
[U89336] HLA class III region [AF109135] archvillin TOM1 [AJ006973]
[AC005390] chr 19, cosmid R31180 PM5 [X57398]
4 unknowns CAPN3 [X85030]
2 unknowns also expressed at 72 hours 2 unknowns also expressed at 48 hours
MYOM1 [X69090]
KRT8 [M34225]
PTPRT [AL024473]
PLCE [D42108]
RPS6KA3 [L07599]
ZNF143 [U09850]
HIVEP1 [M32019]
BRD1 [Z98885]
SMARCB1 [U04847]
TAF2A [D90359]
GCN1L1 [U77700]
HK1 [M75126]
1 unknown
Down-regulated (↓)
MTM1 [U46024] PP32R1 [AF008216] PP32R1 [AF008216]
NEF3 [Y00067] [AB002804] hSLK; KIAA 0204 HNF4A [Z49825]
[D30758] KIAA 0050 RB1 [L41870]
3 unknowns ↑ with culture [S78653] mrg
DPP3 [AB017970] ↑ with culture
1 unknown ↑ with culture
2 unknowns
Human Genome Nomenclature Committee–approved gene names and GenBank Accession Numbers [square brackets]. Non-approved gene names follow
the Accession Number.
unknown genes (Table I) during the three different time
periods studied. The culturing of the vein segments (Sets
2, 4, and 6) resulted in the up-regulated expression of nine
identified and seven unknown genes and in the down-
regulated expression of five identified and seven unknown
genes (Table II) at the same three time points.
DISCUSSION
Crush injury was associated with distinct changes in
gene expression as compared with cultured segments that
were not crush-injured, which shows that injury by itself
caused changes in gene expression that were not the result
of the conditions of organ culture alone. The temporal
sequence of changes in gene expression indicates that the
modulation that occurs in response to injury is predomi-
nately under the endogenous control of the cells in the
vein segment because systemic factors known to affect this
response are not available in culture.
The possibility that macrophages or platelets remain
adherent to the vein segments and are the cause of
changes in gene expression must be considered. The
determination would be possible of whether “hitchhiker”
cells are present and of which cells are responsible for spe-
cific gene expression with in situ hybridization techniques.
Also possible would be the determination of which cells
contain the products of such gene expression with
immunohistochemical staining techniques.
The specific cell types that are responsible for the
changes in gene expression are of great interest, but the
determination of the sequence of changes in broad cate-
gories of gene expression may be equally important. With
the grouping of genes according to the physiologic
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processes (migration, proliferation, production of extra-
cellular matrix) that have been associated with vein graft
stenosis in animal models, identification of genes that
specifically control vein wall responses to injury may be
possible. Such changes, to the extent that they are unique
for human vascular tissue, represent potential therapeutic
targets.
The down-regulation or absence of expression of
genes associated with vascular cell proliferation and the
up-regulation of genes associated with the inhibition of
proliferation was surprising. Organ culture (Sets 2, 4, and
6) induced the down-regulation of transforming growth
factor–β2 (Table II) and of platelet-derived growth fac-
tor–B chain (Table II). This down-regulation persisted in
the sets of vein segments that were crush injured (Sets 3,
5, and 7). In our validation of the model used in this
study,2 we were able to manipulate the inhibition of pro-
liferation with the addition of fetal bovine serum (FBS) to
the culture medium used in this study. In that study, we
found that proliferation was initiated by the addition of
FBS or plasma to the culture medium, which caused a
marked proliferative response by 48 hours in culture. FBS
has been shown to contain the growth factors insulin-like
growth factor–1 and platelet-derived growth factor.5 In
the absence of systemic factors that stimulate cell prolifer-
ation, the endogenous response of saphenous vein to
injury in organ culture may not involve early initiation of
cell proliferation.
Crush injury further suppressed a proliferative
response in the vein segments with the up-regulation of
genes that oppose proliferation or the down-regulation of
genes that support proliferation. Both inducible nitric
Table II. Culture-modulated gene expression
24-Hour organ culture (Set 2) 48-Hour organ culture (Set 4) 72-Hour organ culture (Set 6)
Up-regulated (↑)
PLEC1 [U53204] PLEC1 [U53204] PLEC1 [U53204]
SVIL [AF051850] SVIL [AF051850] SVIL [AF051850]
ACVR2B [X77533] ACVR2B [X77533] ACVR2B [X77533]
SFR56 [U30883] SFR56 [U30883] SFR56 [U30883]
[X69838] G9A [X69838] G9A [X69838] G9A
1 unknown also at 48 and 72 hours 1 unknown also at 24 and 72 hours 1 unknown also at 24 and 48 hours
1 unknown [AF049884] ArgBP2
3 unknowns ↓ with injury NR3C2 [M16801]
DPP3 [AB017970] ↓ with injury
KRT10 [X14487]
[D80010] KIAA 0188
1 unknown ↓ with injury
Down-regulated (↓)
PDGFB [M12783] PDGFB [M12783] PDGFB [M12783]
TGFB2 [Y00083] TGFB2 [Y00083] TGFB2 [Y00083]
IGHV [L03179] IGHV [L03179] IGHV [L03179]
SPTB [J05500] SPTB [J05500] SPTB [J05500]
PDK4 [U54617] PDK4 [U54617] PDK4 [U54617]
[AB002374] KIAA 0376 [AB002374] KIAA 0376 [AB002374] KIAA 0376
5 unknowns also at 48 and 72 hours 5 unknowns also at 24 and 72 hours 5 unknowns also at 24 and 48 hours
1 unknown
Human Genome (HUGO) Nomenclature Committee–approved gene names and GenBank Accession Numbers [square brackets]. Non-approved gene
names follow the Accession Number.
oxide synthase (Sets 3 and 7) and toxic oxygen metabo-
lite–1 (Set 7), inhibitors of cell proliferation, were up-
regulated with crush injury (Table I). Crush injury also
down-regulated acidic nuclear phosphoprotein 32 related-
1 retinoblastoma 1 (Sets 5 and 7) and RB1 (Set 5), both
of which are required for cell proliferation (Table I). The
gene mrg, which is thought to modulate intracellular
angiotensin II actions,6 was down-regulated with crush
injury. Because angiotensin II induces vascular smooth
muscle cell proliferation, the down-regulation of mrg may
be another anti-proliferative response of the injured vascu-
lar tissue in culture media without undefined supplemen-
tation, such as FBS.
In addition, crush-injury resulted in the expression of
the trk protooncogene (NTRK1; Sets 5 and 7). The pro-
tein product of trk is a member of the insulin family of
tyrosine-protein kinases and is involved in the survival, dif-
ferentiation, and maintenance of many cell types.7 Perhaps
trk expression is a survival response of the living cells to
the adjacent vascular necrotic tissue.
Simultaneous with the antiproliferative response, the
expression of matrix proteases and cytoskeletal elements
associated with cell mobility were being up-regulated
(Table I). Secreted proteases are recognized to be associ-
ated with cell migration.8 Matrix protease secretion has
been correlated with the migration of vascular smooth
muscle cells from both animals9,10 and humans.11 In this
study, the secreted proteases that were expressed included
matrix metalloproteinase–9 (Set 3), matrix metallopro-
teinase–23B (Set 3), PM5 (Set 7), and probably serine pro-
teases encoded on cosmid R31180 of chromosome 19 (Set
5; Tables I and III, online only). Likewise, for cells to
migrate, their cytoskeleton must be able to move, which is
consistent with the expression of the following mobile
cytoskeletal elements that we observed: EGF-containing,
fibrillin-like extracellular matrix protein 1 (Set 5), archvillin
(Set 5), calpain (a protease that modifies the cytoskeleton
for remodeling; Set 7) and myomesin 1 (Set 7; Tables I and
III, online only). Also consistent with this suggestion of
up-regulated proteases supporting migration was the
down-regulation of hepatocyte nuclear factor 4 alpha
(HNF4A) (Set 7). The gene product of HNF4A acts
within the nucleus to up-regulate expression of the serpin
gene cluster. Serpins are a family of protease inhibitors.
Thus, up-regulation of proteases, necessary for migration,
was coordinated with down-regulation of protease
inhibitor (serpins) in injured vein (Set 7).
The only up-regulated inflammatory mediator that we
identified was inducible nitric oxide synthase (Sets 3 and
7), which is known to be expressed in response to stimu-
lation with interleukin-1β.12 This finding highlighted
some of the limitations of the RFDD technique. The
RFDD technique depends on the restriction cutting of the
complementary DNA presented for analysis. For a specific
sequence to be analyzable with RFDD, that sequence
must contain at least two restriction sites. We know that at
least one expressed gene of interest, interleukin-1β, which
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we have shown with multiplex polymerase chain reaction
to be up-regulated with injury of human atherosclerotic
tibial artery in organ culture (unpublished results), has
only one Taq1 restriction site, not the two required for
RFDD analysis. This relevant molecule, and probably oth-
ers, is not detectable with the technique used in this study.
A second limitation of the RFDD technique is the fact
that the amplified restriction fragments are displayed on a
sequencing gel, which limits the size range of analyzable
fragments to an approximate range from 100 to 250 base
pairs (Fig 1, scale). This is a significant limitation because
many bands appear outside this range, but the uncertainty
in their size makes identification of the expressed genes
difficult. Although positive identification of interesting
fragments can be accomplished with the excision and
sequencing of the band of interest, the cost of doing so for
the 30 unidentified expressed sequences that we found
would be prohibitive. Currently available gene arrays are
better for studies of gene expression changes because
more known genes can be studied per sample and their
expression levels can be more precisely determined.13
The use of gene arrays in vascular tissue experiments
conducted in vitro would allow for the investigation of the
mechanism of the response to injury. Antisense oligonu-
cleotides, antibodies to receptors, or pharmacologic
agents could be used to specifically block gene expression
for the determination of which of the changes in gene
expression soon after injury are necessary for the progres-
sion of physiologic processes responsible for vein graft
stenosis.
Further study results may confirm an endogenously
modulated response of the vein to injury that initially pre-
pares for the process of cell migration, as suggested in this
study. Organ culture of syngeneic vein is significant to the
study of the human vascular response to injury because it
allows the species-specific analysis of the sequence of gene
expression over time in controlled conditions.
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